Finally, rBCG::IL-18 [49] and rBCG::PTA [96] have been demonstrated to reduce Th2 cytokine production and eosophil influx in the lungs, as well as to improve lung function in ovalbumin mouse models of allergic asthma. This evidence concerns the gene IL18 and allergic asthma.